Max Robotics — Global Service Robot Directory + US Certification

About

Peter L. Oliver is a molecular neuroscientist whose research bridges the genetics of childhood leukemia and cerebellar development. His most influential work centers on the AF4 protein, a transcription factor first identified as a fusion partner in mixed-lineage leukemia (MLL) translocations. In a landmark 2006 study (308 citations), Oliver demonstrated that AF4 stimulates RNA polymerase II transcriptional elongation and coordinates chromatin remodeling, providing the first mechanistic insight into how this leukemia-associated protein drives gene expression. Remarkably, Oliver also uncovered AF4's critical role in the nervous system through his characterization of the *robotic* mouse mutant (72 citations), which exhibits cerebellar ataxia and Purkinje cell loss due to an AF4 mutation. He further showed that AF4 regulates the IGF-1 signaling pathway during Purkinje cell development (27 citations) and identified Siah proteins as mediators of AF4 function in the cerebellum (53 citations). This dual discovery—linking a leukemia oncogene to neurodegeneration—represents a major contribution to understanding shared molecular pathways in cancer and neurological disease. Oliver's work has been cited over 500 times, establishing him as a leading figure in transcriptional regulation and cerebellar biology.